Pollak Michael N

Top coauthors of Pollak Michael N

Hankinson Susan E (24 papers)

Stampfer Meir J (15 papers)

Fuchs Charles S (13 papers)

Azoulay Laurent (12 papers)

Ma Jing (12 papers)

List of Pollak Michael N publications

2017

Abrahami Devin, Yin Hui, Yu Oriana H Y, Pollak Michael N, Azoulay Laurent 2017. "Incretin-based drugs and the incidence of colorectal cancer in patients with type 2 diabetes." Epidemiology (Cambridge, Mass.) doi:10.1097/EDE.0000000000000793
Farland Leslie V, Mu Fan, Eliassen A Heather, Hankinson Susan E, Tworoger Shelley S, et al. 2017. "Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women." Cancer causes & control : CCC 28 (12) doi:10.1007/s10552-017-0971-2
Santo Loredana, Teras Lauren R, Giles Graham G, Weinstein Stephanie J, Albanes Demetrius, et al. 2017. "Circulating resistin levels and risk of multiple myeloma in three prospective cohorts." British journal of cancer 117 (8) doi:10.1038/bjc.2017.282
Hofmann Jonathan N, Mailankody Sham, Korde Neha, Wang Ye, Tageja Nishant, et al. 2017. "Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease." Obesity (Silver Spring, Md.) 25 (8) doi:10.1002/oby.21894
Sanders Jason L, Guo Wensheng, O'Meara Ellen S, Kaplan Robert C, Pollak Michael N, et al. 2017. "Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study." The journals of gerontology. Series A, Biological sciences and medical sciences doi:10.1093/gerona/glx143
Liao Linda M, Hofmann Jonathan N, Cho Eunyoung, Pollak Michael N, Chow Wong-Ho, Purdue Mark P 2017. "Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial." Cancer causes & control : CCC 28 (7) doi:10.1007/s10552-017-0901-3
Alemán José O, Iyengar Neil M, Walker Jeanne M, Milne Ginger L, Da Rosa Joel Correa, et al. 2017. "Effects of Rapid Weight Loss on Systemic and Adipose Tissue Inflammation and Metabolism in Obese Postmenopausal Women." Journal of the Endocrine Society 1 (6) doi:10.1210/js.2017-00020

2016

Babic Ana, Bao Ying, Qian Zhi Rong, Yuan Chen, Giovannucci Edward L, et al. 2016. "Pancreatic cancer risks associated with prediagnostic plasma levels of leptin and leptin receptor genetic polymorphisms." Cancer research doi:10.1158/0008-5472.CAN-16-1699
Hicks Blánaid M, Yin Hui, Yu Oriana H Y, Pollak Michael N, Platt Robert W, Azoulay Laurent 2016. "Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink." BMJ (Clinical research ed.) 355 doi:
Klil-Drori Adi J, Azoulay Laurent, Pollak Michael N 2016. "Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?" Nature reviews. Clinical oncology doi:10.1038/nrclinonc.2016.120
Hayes Brian D, Brady Lauren, Pollak Michael N, Finn Stephen 2016. "Exercise and prostate cancer: evidence and proposed mechanisms for disease modification." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology doi:10.1158/1055-9965.EPI-16-0223
Teumer Alexander, Qi Qibin, Nethander Maria, Aschard Hugues, Bandinelli Stefania, et al. 2016. "Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits." Aging cell doi:10.1111/acel.12490
Lian Yi, Yin Hui, Pollak Michael N, Carrier Serge, Platt Robert W, et al. 2016. "Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer." European urology doi:10.1016/j.eururo.2016.04.035
Chapman Judith-Anne W, Sgroi Dennis C, Goss Paul E, Zarella Elizabeth, Binns Shemeica, et al. 2016. "Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14." Breast cancer research and treatment doi:10.1007/s10549-016-3806-z
Inamura Kentaro, Song Mingyang, Jung Seungyoun, Nishihara Reiko, Yamauchi Mai, et al. 2016. "Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status." Journal of the National Cancer Institute 108 (4) doi:10.1093/jnci/djv363
Travis Ruth C, Appleby Paul N, Martin Richard M, Holly Jeff Mp, Albanes Demetrius, et al. 2016. "A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk." Cancer research doi:10.1158/0008-5472.CAN-15-1551
Hofmann Jonathan N, Birmann Brenda M, Teras Lauren R, Pfeiffer Ruth M, Wang Ye, et al. 2016. "Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals." Cancer research doi:10.1158/0008-5472.CAN-15-2406

2015

Chapman Judith-Anne W, Costantino Joseph P, Dong Bin, Margolese Richard G, Pritchard Kathleen I, et al. 2015. "Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29." Breast cancer research and treatment 153 (2) doi:10.1007/s10549-015-3547-4
Mu Fan, Hankinson Susan E, Schernhammer Eva, Pollak Michael N, Missmer Stacey A 2015. "A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis." American journal of epidemiology 182 (2) doi:10.1093/aje/kwv037
Kordes Sil, Pollak Michael N, Zwinderman Aeilko H, Mathôt Ron A, Weterman Mariëtte J, et al. 2015. "Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial." The Lancet. Oncology 16 (7) doi:10.1016/S1470-2045(15)00027-3
Cao Yin, Nimptsch Katharina, Shui Irene M, Platz Elizabeth A, Wu Kana, et al. 2015. "Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer." International journal of cancer 136 (10) doi:10.1002/ijc.29295
Cifarelli Vincenza, Lashinger Laura M, Devlin Kaylyn L, Dunlap Sarah M, Huang Jennifer, et al. 2015. "Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms." Diabetes 64 (5) doi:10.2337/db14-1132
Assayag Jonathan, Pollak Michael N, Azoulay Laurent 2015. "The use of aspirin and the risk of mortality in patients with prostate cancer." The Journal of urology 193 (4) doi:10.1016/j.juro.2014.11.018
Houghton Lauren C, Pollak Michael N, Tao Yuzhen, Tu Ying Gang, Black Amanda, et al. 2015. "Similarity of Serum and Plasma Insulin-like Growth Factor Concentrations." Biomarkers in cancer 7 doi:10.4137/BIC.S23088

2014

Chapman Judy-Anne W, Pritchard Kathleen I, Goss Paul E, Ingle James N, Muss Hyman B, et al. 2014. "Competing risks of death in younger and older postmenopausal breast cancer patients." World journal of clinical oncology 5 (5) doi:10.5306/wjco.v5.i5.1088
DeCensi Andrea, Puntoni Matteo, Gandini Sara, Guerrieri-Gonzaga Aliana, Johansson Harriet Ann, et al. 2014. "Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial." Breast cancer research and treatment 148 (1) doi:10.1007/s10549-014-3141-1
Assayag Jonathan, Pollak Michael N, Azoulay Laurent 2014. "Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer." European journal of cancer (Oxford, England : 1990) 50 (16) doi:10.1016/j.ejca.2014.08.006
Bensimon Leah, Yin Hui, Suissa Samy, Pollak Michael N, Azoulay Laurent 2014. "The use of metformin in patients with prostate cancer and the risk of death." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 23 (10) doi:10.1158/1055-9965.EPI-14-0056
Mayers Jared R, Wu Chen, Clish Clary B, Kraft Peter, Torrence Margaret E, et al. 2014. "Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development." Nature medicine 20 (10) doi:10.1038/nm.3686
Bridges Hannah R, Jones Andrew J Y, Pollak Michael N, Hirst Judy 2014. "Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria." The Biochemical journal 462 (3) doi:10.1042/BJ20140620
Lai Gabriel Y, Giovannucci Edward L, Pollak Michael N, Peskoe Sarah B, Stampfer Meir J, et al. 2014. "Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study." Cancer causes & control : CCC 25 (5) doi:10.1007/s10552-014-0369-3
de Bono Johann S, Piulats Josep M, Pandha Hardev S, Petrylak Daniel P, Saad Fred, et al. 2014. "Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer." Clinical cancer research : an official journal of the American Association for Cancer Research 20 (7) doi:10.1158/1078-0432.CCR-13-1869
Borugian Marilyn J, Spinelli John J, Gordon Paula B, Abanto Zenaida, Brooks-Wilson Angela, et al. 2014. "Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada)." Cancer causes & control : CCC 25 (3) doi:10.1007/s10552-014-0339-9
Bensimon Leah, Yin Hui, Suissa Samy, Pollak Michael N, Azoulay Laurent 2014. "Type 2 diabetes and the risk of mortality among patients with prostate cancer." Cancer causes & control : CCC 25 (3) doi:10.1007/s10552-013-0334-6
Friedbichler Katrin, Hofmann Marco H, Kroez Monika, Ostermann Elinborg, Lamche Herbert R, et al. 2014. "Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin." Molecular cancer therapeutics 13 (2) doi:10.1158/1535-7163.MCT-13-0598
Bramwell Vivien H C, Tuck Alan B, Chapman Judith-Anne W, Anborgh Pieter H, Postenka Carl O, et al. 2014. "Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial." Breast cancer research : BCR 16 (1) doi:10.1186/bcr3600

2013

Zu Ke, Martin Neil E, Fiorentino Michelangelo, Flavin Richard, Lis Rosina T, et al. 2013. "Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22 (11) doi:10.1158/1055-9965.EPI-13-0349
Smiechowski Brielan, Azoulay Laurent, Yin Hui, Pollak Michael N, Suissa Samy 2013. "The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22 (10) doi:10.1158/1055-9965.EPI-13-0196
Ahern Thomas P, Hankinson Susan E, Willett Walter C, Pollak Michael N, Eliassen A Heather, Tamimi Rulla M 2013. "Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22 (10) doi:10.1158/1055-9965.EPI-13-0375
Wolpin Brian M, Bao Ying, Qian Zhi Rong, Wu Chen, Kraft Peter, et al. 2013. "Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer." Journal of the National Cancer Institute 105 (14) doi:10.1093/jnci/djt123
Moiseeva Olga, Deschênes-Simard Xavier, St-Germain Emmanuelle, Igelmann Sebastian, Huot Geneviève, et al. 2013. "Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation." Aging cell 12 (3) doi:10.1111/acel.12075
Fendt Sarah-Maria, Bell Eric L, Keibler Mark A, Davidson Shawn M, Wirth Gregory J, et al. 2013. "Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism." Cancer research doi:10.1158/0008-5472.CAN-13-0080
Bao Ying, Giovannucci Edward L, Kraft Peter, Qian Zhi Rong, Wu Chen, et al. 2013. "Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five u.s. Cohorts." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22 (5) doi:10.1158/1055-9965.EPI-12-1458
Assayag Jonathan, Yin Hui, Benayoun Serge, Pollak Michael N, Suissa Samy, Azoulay Laurent 2013. "Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer." Cancer causes & control : CCC 24 (5) doi:10.1007/s10552-012-0132-6
Bao Ying, Giovannucci Edward L, Kraft Peter, Stampfer Meir J, Ogino Shuji, et al. 2013. "A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts." Journal of the National Cancer Institute 105 (2) doi:10.1093/jnci/djs474
Eichholzer Monika, Platz Elizabeth A, Bienstock Jessica L, Monsegue Deborah, Akereyeni Folasade, et al. 2013. "Racial variation in vitamin D cord blood concentration in white and black male neonates." Cancer causes & control : CCC 24 (1) doi:10.1007/s10552-012-0093-9
Smiechowski Brielan B, Azoulay Laurent, Yin Hui, Pollak Michael N, Suissa Samy 2013. "The use of metformin and the incidence of lung cancer in patients with type 2 diabetes." Diabetes care 36 (1) doi:10.2337/dc12-0740

2012

Rice Megan S, Tworoger Shelley S, Rosner Bernard A, Pollak Michael N, Hankinson Susan E, Tamimi Rulla M 2012. "Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies." Breast cancer research and treatment 136 (3) doi:10.1007/s10549-012-2303-2
Javeshghani Shiva, Zakikhani Mahvash, Austin Shane, Bazile Miguel, Blouin Marie-José, et al. 2012. "Carbon source and myc expression influence the antiproliferative actions of metformin." Cancer research 72 (23) doi:10.1158/0008-5472.CAN-12-2907
Hofmann Jonathan N, Liao Linda M, Pollak Michael N, Wang Ye, Pfeiffer Ruth M, et al. 2012. "A prospective study of circulating adipokine levels and risk of multiple myeloma." Blood 120 (22) doi:10.1182/blood-2012-06-438606
Pollak Michael N 2012. "Investigating metformin for cancer prevention and treatment: the end of the beginning." Cancer discovery 2 (9) doi:10.1158/2159-8290.CD-12-0263
Kaplan Robert C, Bùzková Petra, Cappola Anne R, Strickler Howard D, McGinn Aileen P, et al. 2012. "Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study." The Journal of clinical endocrinology and metabolism 97 (6) doi:10.1210/jc.2011-2967
Ollberding Nicholas J, Cheng Iona, Wilkens Lynne R, Henderson Brian E, Pollak Michael N, et al. 2012. "Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21 (5) doi:10.1158/1055-9965.EPI-11-1105
Algire Carolyn, Moiseeva Olga, Deschênes-Simard Xavier, Amrein Lilian, Petruccelli Luca, et al. 2012. "Metformin reduces endogenous reactive oxygen species and associated DNA damage." Cancer prevention research (Philadelphia, Pa.) 5 (4) doi:10.1158/1940-6207.CAPR-11-0536
Agurs-Collins Tanya, Rohrmann Sabine, Sutcliffe Catherine, Bienstock Jessica L, Monsegue Deborah, et al. 2012. "Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates." Cancer causes & control : CCC 23 (3) doi:10.1007/s10552-011-9893-6
Zakikhani Mahvash, Bazile Miguel, Hashemi Sina, Javeshghani Shiva, Avizonis Daina, et al. 2012. "Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin." PloS one 7 (11) doi:10.1371/journal.pone.0049513
Azoulay Laurent, Yin Hui, Filion Kristian B, Assayag Jonathan, Majdan Agnieszka, et al. 2012. "The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study." BMJ (Clinical research ed.) 344 doi:
Rice Megan S, Tamimi Rulla M, Connolly James L, Collins Laura C, Shen Dejun, et al. 2012. "Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II." Breast cancer research : BCR 14 (2) doi:10.1186/bcr3141

2011

Pritchard Kathleen I, Shepherd Lois E, Chapman Judith-Anne W, Norris Brian D, Cantin Jacques, et al. 2011. "Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29 (29) doi:10.1200/JCO.2010.33.7006
Poole Elizabeth M, Tworoger Shelley S, Hankinson Susan E, Schernhammer Eva S, Pollak Michael N, Baer Heather J 2011. "Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3." American journal of epidemiology 174 (6) doi:10.1093/aje/kwr123
Ng Kimmie, Sargent Daniel J, Goldberg Richard M, Meyerhardt Jeffrey A, Green Erin M, et al. 2011. "Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29 (12) doi:10.1200/JCO.2010.31.7255
Kaplan Robert C, Petersen Ann-Kristin, Chen Ming-Huei, Teumer Alexander, Glazer Nicole L, et al. 2011. "A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3." Human molecular genetics 20 (6) doi:10.1093/hmg/ddq560
Douglas Jason B, Silverman Debra T, Weinstein Stephanie J, Graubard Barry I, Pollak Michael N, et al. 2011. "Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20 (2) doi:10.1158/1055-9965.EPI-10-1024
Nimptsch Katharina, Platz Elizabeth A, Pollak Michael N, Kenfield Stacey A, Stampfer Meir J, et al. 2011. "Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004." International journal of cancer. Journal international du cancer 128 (3) doi:10.1002/ijc.25381
Wu Kana, Feskanich Diane, Fuchs Charles S, Chan Andrew T, Willett Walter C, et al. 2011. "Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer." PloS one 6 (12) doi:10.1371/journal.pone.0028520

2010

Potratz Jenny C, Saunders Darren N, Wai Daniel H, Ng Tony L, McKinney Steven E, et al. 2010. "Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas." Cancer research 70 (21) doi:10.1158/0008-5472.CAN-10-1093
Douglas Jason B, Silverman Debra T, Pollak Michael N, Tao Yuzhen, Soliman Amr S, Stolzenberg-Solomon Rachael Z 2010. "Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19 (9) doi:10.1158/1055-9965.EPI-10-0400
Zakikhani Mahvash, Blouin Marie-José, Piura Esther, Pollak Michael N 2010. "Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells." Breast cancer research and treatment 123 (1) doi:10.1007/s10549-010-0763-9
Schumacher Fredrick R, Cheng Iona, Freedman Matthew L, Mucci Lorelei, Allen Naomi E, et al. 2010. "A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians." Human molecular genetics 19 (15) doi:10.1093/hmg/ddq210
Gill Jasmeet K, Wilkens Lynne R, Pollak Michael N, Stanczyk Frank Z, Kolonel Laurence N 2010. "Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort." The Prostate 70 (8) doi:10.1002/pros.21125
Schairer Catherine, McCarty Catherine A, Isaacs Claudine, Sue Laura Y, Pollak Michael N, et al. 2010. "Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort." Hormones & cancer 1 (2) doi:10.1007/s12672-010-0013-y
Mucci Lorelei A, Stark Jennifer R, Pollak Michael N, Li Haojie, Kurth Tobias, et al. 2010. "Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19 (2) doi:10.1158/1055-9965.EPI-09-0836
Su Xuefen, Colditz Graham A, Willett Walter C, Collins Laura C, Schnitt Stuart J, et al. 2010. "Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease." International journal of cancer. Journal international du cancer 126 (1) doi:10.1002/ijc.24674
Tsilidis Konstantinos K, Brancati Frederick L, Pollak Michael N, Rifai Nader, Clipp Sandra L, et al. 2010. "Metabolic syndrome components and colorectal adenoma in the CLUE II cohort." Cancer causes & control : CCC 21 (1) doi:10.1007/s10552-009-9428-6
Okereke Olivia I, Kurth Tobias, Pollak Michael N, Gaziano J Michael, Grodstein Francine 2010. "Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II." Neuroepidemiology 34 (4) doi:10.1159/000289351

2009

Beauchamp Marie-Claude, Knafo Ariane, Yasmeen Amber, Carboni Joan M, Gottardis Marco M, et al. 2009. "BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide." Gynecologic oncology 115 (2) doi:10.1016/j.ygyno.2009.07.009
Kaplan Robert C, Fitzpatrick Annette L, Pollak Michael N, Gardner Jeffrey P, Jenny Nancy S, et al. 2009. "Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study." The journals of gerontology. Series A, Biological sciences and medical sciences 64 (11) doi:10.1093/gerona/glp036
Karp Daniel D, Pollak Michael N, Cohen Roger B, Eisenberg Peter D, Haluska Paul, et al. 2009. "Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 4 (11) doi:10.1097/JTO.0b013e3181ba2f1d
Rohrmann Sabine, Sutcliffe Catherine G, Bienstock Jessica L, Monsegue Deborah, Akereyeni Folasade, et al. 2009. "Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18 (5) doi:10.1158/1055-9965.EPI-08-0817
Okereke Olivia I, Selkoe Dennis J, Pollak Michael N, Stampfer Meir J, Hu Frank B, et al. 2009. "A profile of impaired insulin degradation in relation to late-life cognitive decline: a preliminary investigation." International journal of geriatric psychiatry 24 (2) doi:10.1002/gps.2089
Wolpin Brian M, Meyerhardt Jeffrey A, Chan Andrew T, Ng Kimmie, Chan Jennifer A, et al. 2009. "Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27 (2) doi:10.1200/JCO.2008.17.9945
Barbieri Michelangela, Paolisso Giuseppe, Kimura Masayuki, Gardner Jeffrey P, Boccardi Virginia, et al. 2009. "Higher circulating levels of IGF-1 are associated with longer leukocyte telomere length in healthy subjects." Mechanisms of ageing and development 130 (11-12) doi:10.1016/j.mad.2009.10.002

2008

Zakikhani Mahvash, Dowling Ryan J O, Sonenberg Nahum, Pollak Michael N 2008. "The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase." Cancer prevention research (Philadelphia, Pa.) 1 (5) doi:10.1158/1940-6207.CAPR-08-0081
Kasper Jocelyn S, Liu Yan, Pollak Michael N, Rifai Nader, Giovannucci Edward 2008. "Hormonal profile of diabetic men and the potential link to prostate cancer." Cancer causes & control : CCC 19 (7) doi:10.1007/s10552-008-9133-x
Gotlieb Walter H, Saumet Julio, Beauchamp Marie-Claude, Gu Jing, Lau Susie, et al. 2008. "In vitro metformin anti-neoplastic activity in epithelial ovarian cancer." Gynecologic oncology 110 (2) doi:10.1016/j.ygyno.2008.04.008
Kaplan Robert C, McGinn Aileen P, Pollak Michael N, Kuller Lewis, Strickler Howard D, et al. 2008. "High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly." American heart journal 155 (6) doi:10.1016/j.ahj.2007.12.031
Okereke Olivia I, Pollak Michael N, Hu Frank B, Hankinson Susan E, Selkoe Dennis J, Grodstein Francine 2008. "Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes." Psychoneuroendocrinology 33 (4) doi:10.1016/j.psyneuen.2008.01.002
Gunter Marc J, Hoover Donald R, Yu Herbert, Wassertheil-Smoller Sylvia, Manson Joann E, et al. 2008. "A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17 (4) doi:10.1158/1055-9965.EPI-07-2686
Kaplan Robert C, McGinn Aileen P, Pollak Michael N, Kuller Lewis, Strickler Howard D, et al. 2008. "Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults." Journal of the American Geriatrics Society 56 (4) doi:10.1111/j.1532-5415.2007.01637.x
van Oijen Marieke, Okereke Olivia I, Kang Jae Hee, Pollak Michael N, Hu Frank B, et al. 2008. "Fasting insulin levels and cognitive decline in older women without diabetes." Neuroepidemiology 30 (3) doi:10.1159/000126909

2007

Singh Rana P, Deep Gagan, Blouin Marie-José, Pollak Michael N, Agarwal Rajesh 2007. "Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft." Carcinogenesis 28 (12) doi:10.1093/carcin/bgm218
Raina Komal, Blouin Marie-José, Singh Rana P, Majeed Noreen, Deep Gagan, et al. 2007. "Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model." Cancer research 67 (22) doi:10.1158/0008-5472.CAN-07-2222
Michaud Dominique S, Wolpin Brian, Giovannucci Ed, Liu Simin, Cochrane Barbara, et al. 2007. "Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 (10) doi:10.1158/1055-9965.EPI-07-0182
Schernhammer Eva S, Tworoger Shelley S, Eliassen A Heather, Missmer Stacey A, Holly Jeff M, et al. 2007. "Body shape throughout life and correlations with IGFs and GH." Endocrine-related cancer 14 (3) doi:10.1677/ERC-06-0080
Wolpin Brian M, Michaud Dominique S, Giovannucci Edward L, Schernhammer Eva S, Stampfer Meir J, et al. 2007. "Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer." Cancer research 67 (16) doi:10.1158/0008-5472.CAN-07-0373
Tworoger Shelley S, Lee I-Min, Buring Julie E, Pollak Michael N, Hankinson Susan E 2007. "Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 (8) doi:10.1158/1055-9965.EPI-07-0319
de Bono Johann S, Attard Gerhardt, Adjei Alex, Pollak Michael N, Fong Peter C, et al. 2007. "Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor." Clinical cancer research : an official journal of the American Association for Cancer Research 13 (12) doi:10.1158/1078-0432.CCR-07-0268
Schaffer Andrea, Koushik Anita, Trottier Helen, Duarte-Franco Eliane, Mansour Nabil, et al. 2007. "Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 (4) doi:10.1158/1055-9965.EPI-06-0924
Lönn Stefan, Inskip Peter D, Pollak Michael N, Weinstein Stephanie J, Virtamo Jarmo, Albanes Demetrius 2007. "Glioma risk in relation to serum levels of insulin-like growth factors." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 (4) doi:10.1158/1055-9965.EPI-06-1010
Kaplan Robert C, McGinn Aileen P, Pollak Michael N, Kuller Lewis H, Strickler Howard D, et al. 2007. "Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke." The Journal of clinical endocrinology and metabolism 92 (4) doi:10.1210/jc.2006-1631
Okereke Olivia, Kang Jae Hee, Ma Jing, Hankinson Susan E, Pollak Michael N, Grodstein Francine 2007. "Plasma IGF-I levels and cognitive performance in older women." Neurobiology of aging 28 (1) doi:10.1016/j.neurobiolaging.2005.10.012
Rich-Edwards Janet W, Ganmaa Davaasambuu, Pollak Michael N, Nakamoto Erika K, Kleinman Ken, et al. 2007. "Milk consumption and the prepubertal somatotropic axis." Nutrition journal 6 doi:10.1186/1475-2891-6-28
Tamimi Rulla M, Cox David G, Kraft Peter, Pollak Michael N, Haiman Christopher A, et al. 2007. "Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study." Breast cancer research : BCR 9 (1) doi:10.1186/bcr1655
Eliassen A Heather, Tworoger Shelley S, Mantzoros Christos S, Pollak Michael N, Hankinson Susan E 2007. "Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 (1) doi:10.1158/1055-9965.EPI-06-0693

2006

Gong Zhihong, Neuhouser Marian L, Goodman Phyllis J, Albanes Demetrius, Chi Chen, et al. 2006. "Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15 (10) doi:10.1158/1055-9965.EPI-06-0477
Schernhammer Eva S, Holly Jeff M, Hunter David J, Pollak Michael N, Hankinson Susan E 2006. "Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II." Endocrine-related cancer 13 (2) doi:10.1677/erc.1.01149
Missmer Stacey A, Spiegelman Donna, Bertone-Johnson Elizabeth R, Barbieri Robert L, Pollak Michael N, Hankinson Susan E 2006. "Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15 (5) doi:10.1158/1055-9965.EPI-05-0848
Rousseau Marie-Claude, Parent Marie-Elise, Pollak Michael N, Siemiatycki Jack 2006. "Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada." International journal of cancer. Journal international du cancer 118 (8) doi:10.1002/ijc.21600
Harris Tiffany G, Strickler Howard D, Yu Herbert, Pollak Michael N, Monrad E Scott, et al. 2006. "Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3)." Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 16 (2) doi:10.1016/j.ghir.2006.01.002
Wei Esther K, Ma Jing, Pollak Michael N, Rifai Nader, Fuchs Charles S, et al. 2006. "C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15 (4) doi:10.1158/1055-9965.EPI-05-0820
Gotlieb Walter H, Bruchim Ilan, Gu Jing, Shi Ying, Camirand Anne, et al. 2006. "Insulin-like growth factor receptor I targeting in epithelial ovarian cancer." Gynecologic oncology 100 (2) doi:10.1016/j.ygyno.2005.09.048

2005

Pinheiro Simone P, Holmes Michelle D, Pollak Michael N, Barbieri Robert L, Hankinson Susan E 2005. "Racial differences in premenopausal endogenous hormones." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14 (9) doi:10.1158/1055-9965.EPI-04-0944
Platz Elizabeth A, Pollak Michael N, Leitzmann Michael F, Stampfer Meir J, Willett Walter C, Giovannucci Edward 2005. "Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era." Cancer causes & control : CCC 16 (3) doi:10.1007/s10552-004-3484-8
Wei Esther K, Ma Jing, Pollak Michael N, Rifai Nader, Fuchs Charles S, et al. 2005. "A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14 (4) doi:10.1158/1055-9965.EPI-04-0661
Schernhammer Eva S, Holly Jeff M, Pollak Michael N, Hankinson Susan E 2005. "Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14 (3) doi:10.1158/1055-9965.EPI-04-0561
Kristal Alan R, King Irena B, Albanes Demetrius, Pollak Michael N, Stanzyk Frank Z, et al. 2005. "Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14 (3) doi:10.1158/1055-9965.EPI-04-0596

2004

Pollak Michael N 2004. "Insulin-like growth factors and neoplasia." Novartis Foundation symposium 262 doi:

2003

Schernhammer Eva S, Hankinson Susan E, Hunter David J, Blouin Marie J, Pollak Michael N 2003. "Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk." International journal of cancer. Journal international du cancer 107 (1) doi:10.1002/ijc.11358
Nomura Abraham M Y, Stemmermann Grant N, Lee James, Pollak Michael N 2003. "Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men." American journal of epidemiology 158 (5) doi:
Saydah Sharon H, Platz Elizabeth A, Rifai Nader, Pollak Michael N, Brancati Frederick L, Helzlsouer Kathy J 2003. "Association of markers of insulin and glucose control with subsequent colorectal cancer risk." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 12 (5) doi:
Pollak Michael N, Foulkes William D 2003. "Challenges to cancer control by screening." Nature reviews. Cancer 3 (4) doi:10.1038/nrc1042
Hussain Maha, Banerjee Mousumi, Sarkar Fazlul H, Djuric Zora, Pollak Michael N, et al. 2003. "Soy isoflavones in the treatment of prostate cancer." Nutrition and cancer 47 (2) doi:10.1207/s15327914nc4702_1

2002

Kucuk Omer, Sarkar Fazlul H, Djuric Zora, Sakr Wael, Pollak Michael N, et al. 2002. "Effects of lycopene supplementation in patients with localized prostate cancer." Experimental biology and medicine (Maywood, N.J.) 227 (10) doi:
Holmes Michelle D, Pollak Michael N, Willett Walter C, Hankinson Susan E 2002. "Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 11 (9) doi:
Holmes Michelle D, Pollak Michael N, Hankinson Susan E 2002. "Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 11 (9) doi:
Missmer Stacey A, Haiman Christopher A, Hunter David J, Willett Walter C, Colditz Graham A, et al. 2002. "A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer." International journal of cancer. Journal international du cancer 100 (3) doi:10.1002/ijc.10473